Penile-sparing modalities are gaining widespread adoption for the management of low-stage penile cancer due to an increasing demonstration of sound oncologic, cosmetic, sexual, psychosocial, and quality of life outcomes. This review aims to provide a comprehensive overview of the respective treatment options in the armamentarium of the practicing urologist in dealing with this rare but problematic condition
Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the U...
Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. Whi...
Diagnosing premalignant penile lesions from benign penile dermatoses presents a unique challenge. Th...
PURPOSE OF REVIEW: To provide an overview of the current state of literature on organ-sparing approa...
Squamous penile carcinoma is an uncommon neoplastic disease with an incidence of one in 100 000 men ...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
Treatment of primary tumour represents one of the main issues in the management of squamous cell car...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
Penile cancer is a rare malignancy with a prevalence of 1 in 100.000 men in developed countries. The...
OBJECTIVES: To analyze the current trends in local therapy approaches in patients with penile carcin...
BackgroundSquamous cell cancer of the penis is an uncommon, aggressive malignancy whit an age-adjust...
Treatment of primary tumour represents one of the main issues in the management of squamous cell car...
Abstract. Penile tumors represent a difficult group of neoplasms requiring effective and curative tr...
Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the U...
Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. Whi...
Diagnosing premalignant penile lesions from benign penile dermatoses presents a unique challenge. Th...
PURPOSE OF REVIEW: To provide an overview of the current state of literature on organ-sparing approa...
Squamous penile carcinoma is an uncommon neoplastic disease with an incidence of one in 100 000 men ...
A systematic review of the current treatment options and of the outcomes of penile carcinoma has bee...
Treatment of primary tumour represents one of the main issues in the management of squamous cell car...
Penile cancer is a rare disease. Most of penile cancer are squamous cell carcinoma. Diagnosis is bas...
In 2021, approximately 122,651 people in the Netherlands were diagnosed with cancer, and one in five...
This review highlights the significant advances made in the diagno-sis and management of penile canc...
Penile cancer is a rare malignancy with a prevalence of 1 in 100.000 men in developed countries. The...
OBJECTIVES: To analyze the current trends in local therapy approaches in patients with penile carcin...
BackgroundSquamous cell cancer of the penis is an uncommon, aggressive malignancy whit an age-adjust...
Treatment of primary tumour represents one of the main issues in the management of squamous cell car...
Abstract. Penile tumors represent a difficult group of neoplasms requiring effective and curative tr...
Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the U...
Penile cancer is an aggressive disease and after systemic progression it is virtually incurable. Whi...
Diagnosing premalignant penile lesions from benign penile dermatoses presents a unique challenge. Th...